CVS vs GDRX
CVS: CVS Health is an integrated health care giant combining extensive retail pharmacy networks, pharmacy benefits management, and comprehensive health insurance offerings to simplify consumer health experiences. GDRX: GoodRx is a leading digital healthcare platform that provides price transparency and discount tools to help Americans save money on prescription medications and access healthcare services.
Side-by-side fundamentals
| Metric | CVS | GDRX | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $108.08 | $2.93 | |
| Market cap as of 2026-07-23 | $140.4B | $992M | |
| P/E as of 2026-07-23 | 47.90 | 48.27 | CVS lower |
| PEG as of 2026-07-23 | 3.33 | -39.73 | GDRX lower |
| Net margin as of 2026-07-23 | +0.7% | +2.6% | GDRX higher |
| Gross margin as of 2026-07-23 | +13.9% | +91.8% | GDRX higher |
| Operating margin as of 2026-07-23 | +1.6% | +9.9% | GDRX higher |
| ROE as of 2026-07-23 | +3.9% | +3.3% | CVS higher |
| ROA as of 2026-07-23 | +1.1% | +1.4% | GDRX higher |
| Debt / equity as of 2026-07-23 | 0.81 | 0.78 | GDRX lower |
| Revenue growth (YoY) as of 2026-07-23 | +7.6% | -1.2% | CVS higher |
| Revenue CAGR (3y) SEC XBRL | +7.6% | +1.3% | CVS higher |
| Dividend yield as of 2026-07-23 | +2.4% | n/a | |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-07-23 | 0.59 | 1.59 | |
| 1-year return as of 2026-07-22 close | +76.9% | -40.4% | CVS higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.